Mammary hipertrophy
Conditions
Interventions
Cephalothin 2g intravenous administration in single dose 30 minutes before mammaplasty surgery in a experimental group of 75 patients and other 75 patients control group without the use of antibiotic
Drug
Sponsors
Hospital Agamenon Magalhaes
Hospital Agamenon Magalhaes
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: woman, age from 18 to 70 years old, approved by the hospital medical joint comission; body mass index between 25 to 30
Exclusion criteria
Exclusion criteria: Using steroids ; have used antibiotics in the last 7 days prior to the surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of surgical site infection rates in the group with antibiotic prophylaxis when compared to antibiotic-free control group after follow-up for 35 days after surgery, observing the surgical wound behavior weekly and throught statistical evaluation of the data, with absolute and relative frequencies for categoric variables (surgical site infection, prophylactic antibiotic, ptosis, hypertrophy) and mean, standard deviation and median for numeric variables (weight resected, surgery time)with an error margin of 5% to define its statistical significance | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected | — |
Countries
Brazil
Contacts
Public ContactLuiz Felipe Fernandes Vieira
Hospital Agamenon Magalhaes
Outcome results
None listed